Biogen Idec Receives PDUFA Date Extension for ALPROLIX from FDA

Biogen Idec (NASDAQ: BIIB ) announced today that the U.S. Food and Drug Administration (FDA) has extended the initial Prescription Drug User Fee Act (PDUFA) date for its